Cleared Traditional

K885246 - ADVANTAGE

K885246 is an FDA 510(k) clearance for ADVANTAGE, manufactured by Clark Davis Medical Systems, Inc.. The device is a Class 2 Neurology device with product code GWF cleared through the Traditional 510(k) pathway after a 67-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1989
Decision
67d
Days
Class 2
Risk

K885246 is an FDA 510(k) clearance for the ADVANTAGE. Classified as Stimulator, Electrical, Evoked Response (product code GWF), Class II - Special Controls.

Submitted by Clark Davis Medical Systems, Inc. (London, Ontario, CA). The FDA issued a Cleared decision on February 27, 1989 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1870 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K885246

510(k) Number K885246 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 1988
Decision Date February 27, 1989
Days to Decision 67 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d faster than avg
Panel avg: 149d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWF Device Classification - Class 2, Special Controls

Product Code GWF Stimulator, Electrical, Evoked Response
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1870
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWF Stimulator, Electrical, Evoked Response

All 140
Devices cleared under the same product code (GWF) and FDA review panel - the closest regulatory comparables to K885246.
CANTATA EMG/EVOKED RESPONSE SYSTEM
K896567 · Dantec Medical, Inc. · Feb 1990
MODEL 4000 EVOKED POTENTIAL MEASUREMENT SYSTEM
K894608 · Micro-Shev , Ltd. · Dec 1989
MEM-7102
K890274 · Nihon Kohden America, Inc. · May 1989
TECA/MEDELEC 'CONCEPT' P420
K884870 · Teca, Inc. · Feb 1989
NEURAL MAGNETIC STIMULATOR, THE D190
K883340 · Tracor Northern, Inc. · Dec 1988
DANTEC MAGNETIC STIMULATOR
K881915 · Dantec Electronics, Inc. · Oct 1988